SEARCH   
MEMBER LOGIN    

Multiple Sclerosis (MS) Treatment Manufacturing in the US: Market Research Report

Market Research • Market Size • Industry Statistics • Industry Analysis • Industry Trends

Multiple Sclerosis (MS) Treatment Manufacturing Market Research Report | Life Sciences | Prescription Drugs | 2012

The Multiple Sclerosis (MS) Treatment Manufacturing market research report provides key industry analysis and industry statistics, measures market size, analyzes current and future industry trends and shows market share for the industry’s largest companies. IBISWorld publishes the largest collection of industry reports so you can see an industry’s supply chain, economic drivers and key buyers and markets.

Report Snapshot
Market Share of Companies
Biogen Idec Biogen Idec market share
Elan Corporation PLC Elan Corporation PLC market share
EMD Serono Inc. EMD Serono Inc. market share
Teva Pharmaceutical Industries Ltd. Teva Pharmaceutical Industries Ltd. market share
Industry Statistics & Market Size
Revenue
Add to Cart
Annual Growth 07-12
Add to Cart
Annual Growth 12-17
Add to Cart
Profit
Add to Cart
Employment
Add to Cart
Businesses
Add to Cart
Industry Analysis & Industry Trends

The industry develops and produces medications that are used to prevent episodes of symptoms and slow the development of disabilities in patients with relapsing-remitting multiple sclerosis (MS). MS is a disease in which the nerves do not function properly, and patients may experience weakness, numbness, loss of muscle coordination and vision problems.... purchase to read more

What is the Multiple Sclerosis (MS) Treatment Manufacturing industry?

This industry specializes in manufacturing drugs that are used to treat multiple sclerosis (MS)... purchase to read more

 


Industry ProductsRelated ReportsTable of Contents
Major products in this industry
Glatiramer acetateInterferon beta-1aInterferon beta-1bMitoxantrone
 
Examples of brands in this Industry
TysabriAvonexRebifCopaxone


View Sample
Quote
Select Clients